Our partner is committed to creating, improving, and prolonging life for individuals facing difficult-to-treat conditions such as infertility, multiple sclerosis, and cancer. With a legacy of over 350 years and deep global roots, they translate groundbreaking scientific discoveries into meaningful healthcare solutions.

This critical hire led the global regulatory strategy for a leading healthcare organization’s oncology and immunology portfolio, focusing on Phase II and III trials for cutting-edge therapies in oncology and autoimmune diseases. The role offered a unique, high-visibility opportunity with no direct reports, acting as the key point person for significant assets and ensuring strategic regulatory alignment across global teams. This individual drove the regulatory pathway, from early development to health authority interactions, with a strong emphasis on impactful, life-changing therapies targeting oncology and autoimmune conditions.